The report provides estimate, forecast and analysis for the influenza market over a global and regional level. The influenza market is in terms of revenue (USD million), for the period from 2015 to 2020, whereas study provides significant information related to market. The study also offers important market dynamics such as Market size, production forecasts along with key factors driving and restraining the market. Additionally, the report includes the study of opportunities, which are available in the influenza market across global level.
This report provides decisive view on the influenza market to the readers, which describes industry growth rate, industry capacity, and industry structure. Study of Porter&rsquos Five Forces model for the influenza market helps to understand competitive landscape in the market. Some additional parameters such as attractiveness analysis, wherein product segments are benchmarked based on their market size and growth rate, in which different segments are benchmarked related to their market size, growth rate and general attractiveness.
The research provides influenza market bifurcating it into influenza viruses and its vaccines. Influenza viruses includes influenza type A, influenza type B, influenza type C. All the market distribution on products and application has been analyzed based on present and future trends and the market is estimated from 2015 to 2020.
The report provides global scenario of Influenza Market comprehensive overview and market figures. Moreover, study gives the current and expected demand for main region including Americas, EMEA and Asia Pacific. The report provides detailed bifurcation of global influenza market on the basis of products type such as influenza vaccines and influenza drugs. Similar bifurcation has been provided for the individual region.
The report covers detailed competitive scenario including the market share and company overviews, financial revenues of the key participants to develop their positions in the global market. Some key players in this market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others.
This report segments the global market as follows:
Influenza Market - Product Segment Analysis
Influenza Vaccines
Influenza Drugs
Influenza Market &ndash Regional Analysis
Americas
EMEA (Europe, Middle East and Africa)
Asia Pacific
Table of Content
Chapter 1. Preface
1.1. Report description and scope
1.2. Research methodology
1.2.1. Market research process
1.3. List of abbreviations
Chapter 2. Executive Summary
2.1. Global Influenza Market Revenue, 2014 - 2020 (USD Billion)
2.2. Influenza Market: Snapshot
Chapter 3. Influenza Market – Market Dynamics
3.1. Introduction
3.2. Introduction and Classification
3.2.1. Seasonal Influenza
3.2.2. Pandemic Influenza
3.2.3. Zoonotic or Variant Influenza
3.3. Influenza Season
3.4. Geographical Distribution
3.5. Market Drivers
3.5.1. Increase in Awareness Regarding Influenza
3.5.2. Increase in Industry-Academia Collaborations
3.5.3. Global Action Plan for Influenza Vaccines
3.6. Market Restraints
3.7. Market Trends
3.8. Porter’s Five Forces Analysis
Chapter 4. Market Landscape
4.1. Buying Criteria
4.2. Vendor landscape
4.2.1. competitive Scenario
4.2.1.1. Key News
4.2.1.2. MA’s
4.2.2. Market Share Analysis
4.2.2.1. Sanofi Pasteur
4.2.2.2. F. Hoffmann-La Roche
4.2.2.3. GlaxoSmithKline
4.2.2.4. AstraZeneca
4.2.2.5. Novartis
4.2.3. Other Prominent Vendors
Chapter 5. Market Segmentation by Type of Influenza Virus
5.1. Influenza Type A Viruses
5.2. Influenza Type B Viruses
5.3. Influenza Type C Viruses
Chapter 6. Global H1N1 Vaccines Market
6.1. Market Share
6.2. Market Segmentation
6.3. Market Size and Forecast
6.4. Geographical Segmentation
Chapter 7. Market Segmentation by Product Type
Chapter 8. Global Influenza Drugs Market
8.1. Market Segmentation
8.1.1. M2 Protein inhibitors
8.1.2. Neuraminidase Inhibitors
8.2. Market Size and Forecast
8.3. Key Approved Influenza Drugs
8.3.1. In US
8.3.2. In EU
Chapter 9. Global Influenza Vaccines Market
9.1. Market Segmentation
9.2. Market Size and Forecast
9.3. WHO Recommendation
9.4. Key Approved Influenza Vaccines
9.4.1. In US
9.4.2. In EU
Chapter 10. Geographical Segmentation
Chapter 11. Company Profiles
11.1. AstraZeneca
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Business Segmentation
11.1.4. Business Strategy
11.1.5. Business Segmentation by Revenue
11.1.6. Revenue Comparison 2011-2013
11.1.7. Geographical Segmentation by Revenue
11.1.8. Key Development
11.1.9. SWOT Analysis
11.2. F. Hoffmann-La Roche
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Business Segmentation by Revenue
11.2.4. Geographical Segmentation by Revenue
11.2.5. Business Strategy
11.2.6. Key Development
11.2.7. SWOT Analysis
11.3. GlaxoSmithKline
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Business Segmentation
11.3.4. Business Segmentation by Revenue
11.3.5. Geographical Segmentation by Revenue
11.3.6. Pipeline Products
11.3.7. Business Strategy
11.3.8. Key Development
11.3.9. SWOT Analysis
11.4. Novartis
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Business Segment at ion by Revenue 2013 103
11.4.4. Business Segmentation Revenue Comparison 2012-2013
11.4.5. Geographical Segmentation by Revenue
11.4.6. Business Strategy
11.4.7. Key Development
11.4.8. SWOT Analysis
11.5. Sanofi Pasteur
11.5.1. Key facts
11.5.2. Business Description
11.5.3. Business Strategy
11.5.4. Key Development
11.5.5. SWOT Analysis
